Amylyx Pharmaceuticals Investor Lawsuit: Overstated Drug Potential?
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
- Latest
- Trending
Class action lawsuit filed against Amylyx Pharmaceuticals for securities violations, alleging overstated drug prospects and failure to disclose key information. ...
Roadzen Inc. reports impressive Q3 revenue growth of 372% but also discloses a net loss of $30.57 million. The company's ...
GitLab Inc. (NASDAQ: GTLB) is set to announce its Q4 and year-end financial results, with expectations of strong growth and ...
GreenPower Motor Co. reports a 40% surge in revenues, reaching $34.2 million. Expansion of dealer network and innovative electric buses ...
Beamr Imaging, a video optimization technology company, plans to raise $12 million through a public offering. The funds will support ...
Duluth Trading appoints Heena Agrawal as new CFO, offering an inducement award of 94,000 shares of restricted stock. Positive impact ...
Eltek Ltd., a provider of printed circuit board solutions, plans to raise $10 million through a public offering to expand ...
Optex Systems Holdings, Inc. reports impressive surge in revenue and profit for Q4 2023, with total revenues up 72.5% and ...
Global hedge funds have been buying more stocks in cyclical sectors for the second consecutive week, according to a report ...
The banking crisis of March 2023 raises concerns about the stability of the US banking system. Several mid-sized banks failed, ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.